With an annual dividend yield of 6.68%, Pfizer Inc. (NYSE:PFE) is included among the Top 10 Dividend Stocks with Over 5% Yields and Growing Cash Flows. Wolfe Research Says COVID Uncertainty Continues to Weigh Down Pfizer’s (PFE) Outlook On May 14, Wolfe Research analyst Alexandria Hammond raised the company’s price recommendation for Pfizer Inc. (NYSE:PFE)…
Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Pfizer to exit ViiV Healthcare as GSK and Shionogi reshape ownership Reuters reported on Jan. 20 that Britain’s GSK and Japan’s Shionogi said Pfizer Inc. (NYSE:PFE) will exit their HIV-focused joint venture, ViiV Healthcare. The transaction values ​​Pfizer’s exit at around $1.9 billion…
Founded 170 years ago and currently headquartered in New York, Pfizer Inc. (PFE) is a global biopharmaceutical powerhouse with a presence in more than 125 countries. Basically, Pfizer researches, develops, manufactures and markets medicines and vaccines across a broad spectrum: from oncology to immunology, internal medicine, rare diseases and preventive vaccines. With a market capitalization…
